Retina EMR & Anti-VEGF Injection Tracking: How Vitreoretinal Practices Run on Software

The injection cycle is the data model

Wet AMD, diabetic macular edema and retinal vein occlusion are managed with anti-VEGF regimens that are themselves little algorithms: fixed monthly dosing, PRN (treat when the OCT says so), or treat-and-extend, where the interval stretches from 4 weeks toward 12–16 as the retina stays dry and snaps back when it doesn’t. Generic clinic software sees a string of unrelated appointments. Retina-capable software sees the regimen: which protocol this eye is on, the current interval, the injection count to date, and the next due date computed from the last visit — per eye, because the right eye may be on 8 weeks while the left is on 4, and conflating them is a clinical error waiting to happen.

The overdue list is a safety system

Every retina practice has them: the patient who felt “the eye is fine” and stopped coming, the family that couldn’t arrange transport, the monsoon month that emptied the schedule. In most specialties a lapsed patient is lost revenue; in retina, a lapsed anti-VEGF patient is often irreversible vision loss in slow motion. The single highest-value feature in vitreoretinal software is therefore a live overdue-injection list — who has crossed their due interval, by how many days, with one-tap WhatsApp or phone follow-up and an audit trail showing the practice tried. Evaluate this feature first; a system without it is asking your staff to run a safety-critical recall program from memory.

Serial OCT is the consult

The retina consult is substantially a comparison: today’s OCT beside the last three, central thickness trending, fluid present or resolved. The software requirement goes past “can attach images” — scans (including DICOM) must land against the correct visit and eye, open side by side with priors in seconds, and support annotation for counselling. Fundus photographs and angiography belong on the same record. If the OCT lives on the machine’s hard disk and the EMR says “OCT done,” the record is split exactly where the medicine happens.

High-value vials change the inventory game

Anti-VEGF agents are among the most expensive consumables in outpatient medicine — a single vial can exceed the price of a month of clinic software, and injection days consume them in batches. The practice needs stock-aware handling: vials received, allocated to injection lists, billed to the correct patient, with expiry visibility so nothing costly quietly lapses. Where compounded or shared agents are used, batch-level records matter even more, because in the rare event of a post-injection infection cluster, the first question asked is “which batch, which patients?” — and the software should answer it in minutes.

Injection day as a production line

• Consent every time — an intravitreal injection is a procedure; digital consent captured per injection, stored with the record.
• Day-care OT lists — injection sessions run as scheduled lists with the flow board showing who is prepped, who is done.
• Per-eye documentation — agent, eye, batch and findings recorded in seconds through a structured template, not free text.
• Next cycle booked before the patient leaves — the interval decision converted immediately into a dated visit with an automated reminder.
• Billing that separates drug and procedure — the vial, the procedure fee and the consult itemized cleanly for patients and insurers.

India vs USA notes

India: the drug dominates the bill, so transparent vial-plus-procedure invoicing decides patient trust; injection adherence is the daily battle, making WhatsApp recall the workhorse feature; and multi-year records linked to ABHA matter as patients move between centres. Retina-capable software typically runs ₹2,500–₹6,000/month.

USA: retina practices live inside buy-and-bill economics and prior authorization — drug inventory, benefits verification and injection-interval documentation feed directly into reimbursement, and retina EHR stacks commonly run $500–$1,000+ per provider per month once inventory modules are included. In both markets the demo test is the same: show me every patient overdue for an injection today, and show me this eye’s OCT trend across four visits.

How VixitAi HMS runs a real vitreoretinal practice

This is not a theoretical checklist for us: VixitAi HMS runs the daily operations of a retina super-specialty practice in Ranchi, India — its injection-day flow, records, imaging and patient recall.

• A dedicated retina intake template (distinct from general ophthalmology) with per-eye structured findings.
• Imaging in the EMR — OCT and fundus uploads with DICOM support and annotation, encrypted at rest, comparable across visits.
• Digital consent e-signature per procedure and the OT module for injection and surgical lists.
• Patient Flow board tracking injection-day patients station by station, live on a TV display.
• Automated WhatsApp reminders for upcoming cycles and pharmacy inventory with stock and expiry visibility for high-value vials.
• Queue, billing, lab and reports on the same record — from ₹1,999/month.

Buying advice for retina specialists

Bring your injection book to the demo. Pick one real treat-and-extend patient and make the system reproduce their story: protocol, interval changes, per-eye history, the OCTs behind each decision, and the next due date with its reminder. Then ask for the overdue list. Any product that handles a cataract-and-refraction clinic can look adequate for retina in a slide deck; only a system that models the cycle itself will still be adequate in month six, when your census of active injection patients has doubled.

Frequently asked questions

VixitAi HMS plans & pricing

Every plan includes free setup support, data migration and built-in ABHA/ABDM readiness — no per-user charges, no lock-in. Click a plan to sign up directly:

Prefer the details first? See the full pricing page or the live price table with the monthly/yearly toggle.

Read next

← Back to all articles